Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
出版年份 2011 全文链接
标题
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
作者
关键词
-
出版物
NATURE MEDICINE
Volume 17, Issue 4, Pages 461-469
出版商
Springer Nature
发表日期
2011-03-14
DOI
10.1038/nm.2309
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin
- (2010) X. Huang et al. CANCER RESEARCH
- PI(3)King Apart PTEN's Role in Cancer
- (2010) S. Zhang et al. CLINICAL CANCER RESEARCH
- Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells
- (2010) Samuel Seoane et al. JNCI-Journal of the National Cancer Institute
- ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells
- (2010) J. Nautiyal et al. MOLECULAR CANCER THERAPEUTICS
- EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance
- (2009) Rajiv Dua et al. BREAST CANCER RESEARCH AND TREATMENT
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- Trastuzumab-Induced HER Reprogramming in "Resistant" Breast Carcinoma Cells
- (2009) M. Narayan et al. CANCER RESEARCH
- Transforming Growth Factor Induces Clustering of HER2 and Integrins by Activating Src-Focal Adhesion Kinase and Receptor Association to the Cytoskeleton
- (2009) S. E. Wang et al. CANCER RESEARCH
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
- (2008) D. L. Shattuck et al. CANCER RESEARCH
- STAT3 as a target for inducing apoptosis in solid and hematological tumors
- (2008) Khandaker Al Zaid Siddiquee et al. CELL RESEARCH
- Circumventing De Novo and Acquired Resistance to Trastuzumab: New Hope for the Care of ErbB2-Positive Breast Cancer
- (2008) Martine Piccart Clinical Breast Cancer
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started